Business · 10/11/2020Updated: 10/17/2026 · 1 min read
FDA Releases Final Guidance on Increasing Diversity in Clinical Trials
Summary
The Food and Drug Administration (FDA) has released a final guidance to help pharmaceutical companies increase enrollment of underrepresented populations in clinical trials, in part to meet the mandates of the FDA Reauthorization Act of 2017
Original source language: Federal Register — Food and Drug AdministrationOpen original release →